Clinical Trials Browser

Disease Progression × nilotinib × Clear all

NCT01110668 2017-02-28

Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Phase 2 Completed

GastrointestinalSarcoma

Disease Progression, Gastrointestinal Stromal Tumors